WHO suspends clinical trial of Hydroxychloroquine on COVID-19 patients
- Posted By
10Pointer
- Categories
Science & Technology
- Published
27th May, 2020
-
- The World Health Organization (WHO) Director General said that it has temporarily suspended the clinical trial of Hydroxychloroquine (HCQ) on COVID-19 patients.
- The Lancet Medical Journal published an observational study on HCQ and chloroquine and its effect on COVID-19 patients, who were hospitalized.
- The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.
- WHO had initiated the Solidarity Trial, to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19, which include HCQ.
- The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met earlier this week and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally.
- The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug.